Global market
JPM 2020 l The changing landscape of global healthcare in the new decade
I was struck by a resounding shift in attitude at this year’s J.P. Morgan Healthcare Conference; less talk, more action. The atmosphere felt more...
JPM 2019 |The fundamentals remain strong despite the doubters
I’ve taken longer than usual to write my JPM blog this year. It was a week when there was such a division of opinion...
Launching your first medical product in Europe? How not to fail at the first step
So, you have your first product close to launch or are even on the market in the U.S. You’re planning to take it to...
Brexit’s Uncertainty Principle
While the minutiae of the possible upcoming permutations for drug supply depending on various Brexit outcomes have been written about elsewhere, less thought has been...
Bringing fresh talent into the Alzheimer’s space
It’s more than 15 years since the pharmaceutical industry succeeded in launching a new drug to treat Alzheimer’s disease. Since then, over 99% of...
Executive Interims: A creative talent solution for medtech
After attending two recent medtech industry meetings, I was struck by the scale of the two opposing forces that the sector is currently experiencing....
Solving the life sciences talent puzzle in Asia
Living and working in the Asia-Pacific region for the past 7 years has given me a close-up view of the fast growth of its...
Outlook: Medtech 2030
Having travelled in Europe in the last few weeks meeting clients and candidates, I wanted to share some reflections with you linked to one...
Does the European Medicines Agency’s move to Amsterdam presage a brain drain from the UK?
Last week’s long-awaited announcement of the new home for the European Medicines Agency (EMA), from March 2019, puts the big question behind us but...
A Report from BIO-Europe Spring 2017
The blue skies and balmy weather of Barcelona were the perfect backdrop for BIO-Europe Spring this year. The 2,400 biotech pros at the conference...
Report from J.P. Morgan 2017
So, that’s the J.P. Morgan Healthcare Conference done for another year. For just a few highly energised days it felt as if nearly every...
Shaping up for growth in a world of change
The 34th FT Global Pharmaceutical and Biotechnology Conference brought together life science and pharma companies as well as emerging new players. Discussions centered on industry challenges,...